BEXIMCO PHARMA.GDR REGS 1 (R2WA) — Net Asset Quality Index
BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Net Asset Quality Index of 72.7% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €73.80 Billion minus total liabilities of €20.17 Billion yields net assets of €53.63 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check BEXIMCO PHARMA.GDR REGS 1 (R2WA) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
BEXIMCO PHARMA.GDR REGS 1 Net Asset Quality Index Over Time (2021–2024)
This chart shows how BEXIMCO PHARMA.GDR REGS 1's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the index stands at 72.7%, representing net assets of €53.63 Billion against total assets of €73.80 Billion EUR. See BEXIMCO PHARMA.GDR REGS 1 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for BEXIMCO PHARMA.GDR REGS 1 (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see R2WA company net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 74.8% | €51.90 Billion | €69.34 Billion | €17.44 Billion | ▲ +6.0 pp |
| 2023 | 68.9% | €47.62 Billion | €69.16 Billion | €21.54 Billion | ▲ +1.4 pp |
| 2022 | 67.5% | €44.64 Billion | €66.15 Billion | €21.51 Billion | ▼ -4.0 pp |
| 2021 | 71.5% | €37.36 Billion | €52.25 Billion | €14.88 Billion | — |